Change - Announcement of Cessation::Re-designation as Chief Medical Officer and Cessation as Executive Director and Group CEO

Issuer & Securities

Issuer/ Manager
META HEALTH LIMITED
Securities
META HEALTH LIMITED - SG1O81915033 - 5DX
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Cessation
Date &Time of Broadcast
25-Feb-2025 22:19:50
Status
New
Announcement Sub Title
Re-designation as Chief Medical Officer and Cessation as Executive Director and Group CEO
Announcement Reference
SG250225OTHRZ0K7
Submitted By (Co./ Ind. Name)
Gwendolin Lee Soo Fern
Designation
Company Secretary
Description (Please provide a detailed description of the event in the box below)

Re-designation of Dr Bernard Ng Kee Huat as Chief Medical Officer and his cessation as Executive Director and Group Chief Executive Officer.


This announcement has been reviewed by the Company's sponsor, ZICO Capital Pte. Ltd. (the "Sponsor").

This announcement has not been examined or approved by the Singapore Exchange Securities Trading Limited (the "SGX-ST") and the SGX-ST assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made or reports contained in this announcement.

The contact person for the Sponsor is Ms Lim Hui Zheng, ZICO Capital Pte. Ltd. at 77 Robinson Road, #06-03 Robinson 77, Singapore 068896, telephone (65) 6636 4201.

Additional Details

Name Of Person
Bernard Ng Kee Huat
Age
50
Is effective date of cessation known?
Yes
If yes, please provide the date
01/03/2025
Detailed Reason (s) for cessation
As part of the Company's strategic restructuring of its management team, Dr Bernard Ng Kee Huat ("Dr Bernard") will relinquish his role as an Executive Director and Group Chief Executive Officer ("CEO") of the Company and will be re-designated as Chief Medical Officer of the Company, with effect from 1 March 2025, where he will continue to manage the operations and oversee the business strategy of the Group's healthcare business. As Chief Medical Officer, Dr Bernard will also assist Mr Law Ren Kai Kenneth, an incumbent Independent Director of the Company who has been re-designated to Executive Chairman, in the conduct of the Group's daily operational directions and decisions.

Following his cessation as an Executive Director, Dr Bernard will also ceased to be a member of the Audit Committee, the Remuneration Committee and the Nominating Committee.

After having interviewed Dr Bernard and to the best of its knowledge, the Company's sponsor, ZICO Capital Pte. Ltd., is satisfied that, save as disclosed in this announcement, there are no other material reasons for the re-designation of Dr Bernard and his cessation as an Executive Director and Group CEO.
Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting?
No
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer?
No
Any other relevant information to be provided to shareholders of the listed issuer?
No
Date of Appointment to current position
07/06/2022
Does the AC have a minimum of 3 members (taking into account this cessation)?
Yes
Number of Independent Directors currently resident in Singapore (taking into account this cessation)
2
Number of cessations of appointments specified in Listing Rule 704 (7) or Catalist Rule 704 (6) over the past 12 months
5
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Dr Bernard will be re-designated as Chief Medical Officer, following his cessation as an Executive Director and Group CEO.
Role and responsibilities
As Chief Medical Officer, Dr Bernard will manage the operations and oversee the business strategy of the Group's healthcare business, as well as assisting the Executive Chairman in the conduct of the Group's daily operational directions and decisions.
Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries
None.
Shareholding interest in the listed issuer and its subsidiaries?
Yes
Shareholding Details
Direct Interest: 32,769,067 ordinary shares of the Company.
Past (for the last 5 years)
Gain Foods Pte. Ltd. (struck off)
Present
The Safe Space Foundation Ltd.
TS Medical (City Gate) Pte. Ltd.
Gainhealth Pte. Ltd.
MCE Technologies Holdings Pte. Ltd.
5Digital Pte. Ltd.